BrightGene Bio-Medical Technology Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 78,538.27 compared to CNY 50,315.67 a year ago. Operating income was CNY 19,325.79 compared to CNY 12,133.34 a year ago. Net income was CNY 17,007.61 compared to CNY 11,108.33 a year ago. Basic earnings per share from continuing operations was CNY 0.41 compared to CNY 0.3 a year ago.